Following an easy setup process, Resonance Health provides a range of clinical image analysis services of MRI scans via a unique quality assured service delivery model: FerriScan® – the global gold standard for the measurement of liver iron concentration (LIC) Cardiac T2* – assessment of cardiac iron (FerriScan add-on) HepaFat-Scan® – measurement of volumetric liver fat fraction (VLFF) […]
Easy Setup for Radiology Centres Read More »
What is iron overload? Iron overload is the accumulation of excess iron in the body. People who receive multiple blood transfusions in the course of treatment for certain diseases are at particular risk of iron overload as the body has no natural mechanism for excreting iron. One unit of transfused red cells delivers approximately 250mg
Cardiac T2* for Iron Assessment is a service that is offered seperately or as part of a dual analysis package with FerriScan to provide more comprehensive information regarding body iron stores. The Liver and Heart in Iron Overload Changes in liver iron concentration generally precede changes in heart iron loading, acting as an early warning
Cardiac T2* with FerriScan® – Dual Analysis Service Read More »
FerriScan® provides an accurate measurement of liver iron concentration (LIC) through a non-invasive, MRI-based technology. The measurement is performed in a central Service Centre and provided via our unique Quality Assured Service Delivery model. FerriScan® was regulatory cleared by the FDA for the measurement of LIC in 2005. In January 2013 FerriScan gained an additional clearance
FerriScan® – MRI Measurement of Liver Iron Concentration Read More »
Annual Report 2021 Annual Report 2020 Annual Report 2019 Annual Report 2018 Annual Report 2017 Annual Report 2016 Annual Report 2015 Annual Report 2014 Annual Report 2013 Annual Report 2012 Annual Report 2011 Annual Report 2010 Annual Report 2009 Annual Report 2008 Annual Report 2007 Annual Report 2006 Annual Report 2005 Annual Report 2004
Resonance Health is a healthcare company listed on the Australian Stock Exchange (ASX:RHT). Resonance Health provides quantitative MRI based technologies for the diagnosis and monitoring of human disease. Accurate imaging end points are increasingly used in clinical trials, providing quantitative and direct evidence for regulatory submissions. Resonance Health's image analysis laboratory provides quality certified central
Corporate Head Office Address: Resonance Health Limited and Resonance Health Analysis Services Pty Limited 141 Burswood Road Burswood WA 6100 Australia Postal Address: PO Box 71 Burswood WA 6100 Australia T +61 8 9286 5300 F +61 8 9286 5399 General Enquiries info@resonancehealth.com Radiology Centre Enquiries support@resonancehealth.com Investor Enquiries Nicholas Allan info@resonancehealth.com [widgetkit id=2] Contact
Resonance Health provides FerriScan®, Cardiac T2* and HepaFat-Scan® via a unique service model. All patient MRI data is securely transferred to Resonance Health’s central Service Centre where it is analysed by our team of experts and a patient report is returned. Service Model A patient requiring a FerriScan, Cardiac T2* or HepaFat Scan is referred
Quality Assured Service Delivery Read More »
Mr Nick Allan Chief Financial Officer and Company Secretary Mr Nick Allan has over 25 years experience in commerce, corporate finance, accounting, information technology, corporate advisory and public practice. After obtaining a Bachelor of Commerece from the University of Western Australia, Mr Allan qualified as a Chartered Accountant in the UK with Coopers & Lybrand,
Dr Travis Baroni Non Executive Director Dr Travis Baroni has broad experience across industrial research, commercialisation of technology, asset valuations, and investment banking services. He has managed innovation development and technology strategy in a large company setting as well as being an active investor in early stage investments. He has worked in investment banking, providing
INVESTORS
SUPPORT
PATIENTS
PHYSICIANS